🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AGI
$AGIO
🔒 US EquitiesAgios Pharmaceuticals, Inc.
AVG HISTORICAL GAP
-1.73%
MAX GAP RECORD
-15.80%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AGIO
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AGIO
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN) |
-15.80%
|
| Apr 29, 2026 Earnings Release 2026-04-29 (BEFORE OPEN) |
+6.85%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (BEFORE OPEN) |
+0.51%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+0.52%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (BEFORE OPEN) |
-1.70%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (BEFORE OPEN) |
-0.52%
|
| Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN) |
+2.04%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (2)
Bearish Gaps (8)
Neutral / Flat (5)
📖 Intelligence Summary
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗